180 Life Sciences Corp. (NASDAQ: ATNF) At Current Prices: Is It Worth Investing In? – Marketing Sentinel
Home  »  Technologies   »  180 Life Sciences Corp. (NASDAQ: ATNF) At Current ...

180 Life Sciences Corp. (NASDAQ: ATNF) At Current Prices: Is It Worth Investing In?

During the last session, 180 Life Sciences Corp. (NASDAQ:ATNF)’s traded shares were 0.31 million, with the beta value of the company hitting -0.22. At the end of the trading day, the stock’s price was $1.26, reflecting an intraday gain of 14.55% or $0.16. The 52-week high for the ATNF share is $11.75, that puts it down -832.54 from that peak though still a striking 20.63% gain since the share price plummeted to a 52-week low of $1.00. The company’s market capitalization is $41.93M, and the average trade volume was 396.40K shares over the past three months.

180 Life Sciences Corp. (ATNF) received a consensus recommendation of a Hold from analysts. That translates to a mean rating of 2.00. ATNF has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.13.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

180 Life Sciences Corp. (NASDAQ:ATNF) trade information

180 Life Sciences Corp. (ATNF) registered a 14.55% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 14.55% in intraday trading to $1.26 this Friday, 05/13/22, hitting a weekly high. The stock’s 5-day price performance is -3.82%, and it has moved by -37.00% in 30 days. Based on these gigs, the overall price performance for the year is -84.33%.

The consensus price target of analysts on Wall Street is $5.00, which implies an increase of 74.8% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $5.00 and $5.00 respectively. As a result, ATNF is trading at a discount of -296.83% off the target high and -296.83% off the low.

While earnings are projected to return 2.00% in 2022.

ATNF Dividends

180 Life Sciences Corp. is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

180 Life Sciences Corp. (NASDAQ:ATNF)’s Major holders

180 Life Sciences Corp. insiders own 35.29% of total outstanding shares while institutional holders control 9.35%, with the float percentage being 14.44%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 45 institutions own stock in it. As of Dec 30, 2021, the company held over 1.0 million shares (or 2.95% of all shares), a total value of $3.92 million in shares.

The next largest institutional holding, with 0.68 million shares, is of Susquehanna International Group, LLP’s that is approximately 1.99% of outstanding shares. At the market price on Dec 30, 2021, these shares were valued at $2.65 million.

Also, the Mutual Funds coming in first place with the largest holdings of 180 Life Sciences Corp. (ATNF) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Dec 30, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 0.71 million shares. This amounts to just over 2.07 percent of the company’s overall shares, with a $2.75 million market value. The same data shows that the other fund manager holds slightly less at 0.27 million, or about 0.79% of the stock, which is worth about $1.05 million.

Leave a Comment

Your email address will not be published.

On Key

Related Posts